z-logo
open-access-imgOpen Access
Runx3 Protects Gastric Epithelial Cells Against Epithelial‐Mesenchymal Transition‐Induced Cellular Plasticity and Tumorigenicity
Author(s) -
Voon Dominic ChihCheng,
Wang Huajing,
Koo Jason Kin Wai,
Nguyen Tu Anh Pham,
Hor Yit Teng,
Chu YehShiu,
Ito Kosei,
Fukamachi Hiroshi,
Chan Shing Leng,
Thiery Jean Paul,
Ito Yoshiaki
Publication year - 2012
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1002/stem.1183
Subject(s) - biology , wnt signaling pathway , epithelial–mesenchymal transition , lgr5 , stem cell , cancer research , microbiology and biotechnology , carcinogenesis , epithelium , beta catenin , mesenchymal stem cell , signal transduction , cancer , metastasis , genetics
The transcription factor RUNX3 functions as a tumor suppressor in the gastrointestinal epithelium, where its loss is an early event in carcinogenesis. While RUNX3 acts concurrently as a mediator of TGF‐β signaling and an antagonist of Wnt, the cellular changes that follow its loss and their contribution to tumorigenicity are not fully understood. Here, we report that the loss of Runx3 in gastric epithelial cells results in spontaneous epithelial‐mesenchymal transition (EMT). This produces a tumorigenic stem cell‐like subpopulation, which remarkably expresses the gastric stem cell marker Lgr5 . This phenomenon is due to the compounding effects of the dysregulation of the TGF‐β and Wnt pathways. Specifically, Runx3 −/− p53 −/− gastric epithelial cells were unexpectedly sensitized for TGF‐β‐induced EMT, during which the resultant induction of Lgr5 was enhanced by an aberrantly activated Wnt pathway. These data demonstrate a protective role for RUNX3 in safeguarding gastric epithelial cells against aberrant growth factor signaling and the resultant cellular plasticity and stemness. S TEM C ells 2012;30:2088–2099

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here